Advertisement

Obésité

, Volume 10, Issue 4, pp 277–282 | Cite as

Obésité et arthrose, du lien mécanique au lien métabolique

  • A. Courties
  • J. Sellam
Mise au Point / Update

Résumé

Ľarthrose est la pathologie articulaire la plus fréquente touchant aussi bien les genoux, les hanches que les mains. Outre le vieillissement et les antécédents de traumatisme articulaire, ľobésité est un facteur de risque majeur ďarthrose des articulations portantes (hanches, genoux). Ceci s’explique par la transduction au niveau des chondrocytes de contraintes mécaniques excessives en un processus ďinflammation articulaire et de dégradation enzymatique du cartilage. Il existe également un lien systémique entre arthrose et obésité, illustré par une augmentation du risque ďarthrose des mains (articulations non portantes) chez les sujets obèses, possiblement expliquée par les adipokines. Au-delà de ľarthrose liée à ľobésité, on définit désormais ľarthrose associée au syndrome métabolique (ou arthrose métabolique) englobant le lien avec ľobésité mais également ľassociation de ľarthrose avec les autres composantes du syndrome métabolique (hypertension artérielle, diabète ou insulino-résistance et dyslipidémie). De nombreux mécanismes physiopathologiques sont communs à ces pathologies telles que ľinflammation chronique de bas grade et le stress oxydant. Cette nouvelle approche de ľarthrose en fonction des phénotypes (métabolique, lié à ľâge ou post-traumatique) devrait permettre ďenvisager de nouvelles perspectives thérapeutiques et de personnaliser la prise en charge des patients.

Mots clés

Obésité Arthrose Adipokines Stress mécanique Syndrome métabolique 

Obesity and osteoarthritis, from the mechanic to the metabolic side

Abstract

Osteoarthritis (OA) is the most common joint disease affecting knees, hips and hands. In addition to aging and history of joint trauma, obesity is a major risk factor for OA of weight bearing joints (hips, knees). It can be explained by the conversion of mechanical stress into joint inflammation and subsequent cartilage degradation process. There is also a systemic link between obesity and OA, illustrated by an increased risk of hand OA (non-weight-bearing joints) in obese subjects, possibly explained by adipokines disturbances. Beyond OA-related obesity, metabolic syndromerelated OA (or “metabolic OA”) is progressively delineated, including the link with obesity but also the association with other components of the metabolic syndrome (i.e., hypertension, diabetes mellitus or insulin resistance and dyslipidemia). Many pathophysiological mechanisms are common to these diseases such as chronic low-grade inflammation and oxidative stress. This new approach of OA based on phenotypes (i.e., metabolic, age-related or post-trauma) should lead to consider new therapeutic prospect and to better tailor patients care.

Keywords

Obesity Osteoarthritis Adipokines Mechanical stress Metabolic syndrome 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. 1.
    Anderson JJ, Felson DT (1988) Factors associated with osteoarthritis of the knee in the first national Health and Nutrition Examination Survey (HANES I). Evidence for an association with overweight, race, and physical demands of work. Am J Epidemiol 128:179–89PubMedGoogle Scholar
  2. 2.
    Lohmander LS, Gerhardsson de Verdier M, Rollof J, et al (2009) Incidence of severe knee and hip osteoarthritis in relation to different measures of body mass: a population-based prospective cohort study. Ann Rheum Dis 68:490–6CrossRefPubMedGoogle Scholar
  3. 3.
    Gosset M, Berenbaum F, Salvat C, et al (2008) Crucial role of visfatin/pre-B cell colony-enhancing factor in matrix degradation and prostaglandin E2 synthesis in chondrocytes: possible influence on osteoarthritis. Arthritis Rheum 58:1399–409CrossRefPubMedGoogle Scholar
  4. 4.
    Yusuf E, Nelissen RG, Ioan-Facsinay A, et al (2010) Association between weight or body mass index and hand osteoarthritis: a systematic review. Ann Rheum Dis 69:761–5CrossRefPubMedGoogle Scholar
  5. 5.
    Gomez R, Conde J, Scotece M, et al (2011) What’s new in our understanding of the role of adipokines in rheumatic diseases? Nat Rev Rheumatol 7:528–36CrossRefPubMedGoogle Scholar
  6. 6.
    Gandhi R, Takahashi M, Syed K, et al (2010) Relationship between body habitus and joint leptin levels in a knee osteoarthritis population. J Orthop Res 28:329–33PubMedGoogle Scholar
  7. 7.
    Seven A, Guzel S, Aslan M, Hamuryudan V (2009) Serum and synovial fluid leptin levels and markers of inflammation in rheumatoid arthritis. Rheumatol Int 29:743–7CrossRefPubMedGoogle Scholar
  8. 8.
    Staikos C, Ververidis A, Drosos G, et al (2013) The association of adipokine levels in plasma and synovial fluid with the severity of knee osteoarthritis. Rheumatology (Oxford) 52:1077–83CrossRefGoogle Scholar
  9. 9.
    Dumond H, Presle N, Terlain B, et al (2003) Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum 48:3118–29CrossRefPubMedGoogle Scholar
  10. 10.
    Hui W, Litherland GJ, Elias MS, et al (2012) Leptin produced by joint white adipose tissue induces cartilage degradation via upregulation and activation of matrix metalloproteinases. Ann Rheum Dis 71:455–62CrossRefPubMedGoogle Scholar
  11. 11.
    Laiguillon MC, Houard X, Bougault C, et al (2014) Expression and function of visfatin (Nampt), an adipokine-enzyme involved in inflammatory pathways of osteoarthritis. Arthritis Res Ther 16:R38CrossRefGoogle Scholar
  12. 12.
    Massengale M, Lu B, Pan JJ, et al (2012) Adipokine hormones and hand osteoarthritis: radiographic severity and pain. PLoS One 7:e47860CrossRefGoogle Scholar
  13. 13.
    Singh G, Miller JD, Lee FH, et al (2002) Prevalence of cardiovascular disease risk factors among US adults with self-reported osteoarthritis: data from the Third National Health and Nutrition Examination Survey. Am J Manag Care 8:S383–91Google Scholar
  14. 14.
    Dahaghin S, Bierma-Zeinstra SM, Koes BW, et al (2007) Do metabolic factors add to the effect of overweight on hand osteoarthritis? The Rotterdam Study. Ann Rheum Dis 66:916–20PubMedCentralCrossRefPubMedGoogle Scholar
  15. 15.
    Schett G, Kleyer A, Perricone C, et al (2013) Diabetes is an independent predictor for severe osteoarthritis: results from a longitudinal cohort study. Diabetes Care 36:403–9PubMedCentralCrossRefPubMedGoogle Scholar
  16. 16.
    Rosa SC, Goncalves J, Judas F, et al (2009) Impaired glucose transporter-1 degradation and increased glucose transport and oxidative stress in response to high glucose in chondrocytes from osteoarthritic versus normal human cartilage. Arthritis Res Ther 11:R80CrossRefGoogle Scholar
  17. 17.
    Berenbaum F (2011) Diabetes-induced osteoarthritis: from a new paradigm to a new phenotype. Ann Rheum Dis 70:1354–6CrossRefPubMedGoogle Scholar
  18. 18.
    Hart DJ, Doyle DV, Spector TD (1995) Association between metabolic factors and knee osteoarthritis in women: the Chingford Study. J Rheumatol 22:1118–23PubMedGoogle Scholar
  19. 19.
    Lippiello L, Walsh T, Fienhold M (1991) The association of lipid abnormalities with tissue pathology in human osteoarthritic articular cartilage. Metabolism 40:571–6CrossRefPubMedGoogle Scholar
  20. 20.
    Alvarez-Garcia O, Rogers NH, Smith RG, Lotz MK (2014) Palmitate has proapoptotic and proinflammatory effects on articular cartilage and synergizes with interleukin-1. Arthritis Rheumatol 2014 Mar 3. doi: 10.1002/art.38399 Google Scholar
  21. 21.
    Wu J, Liu W, Bemis A, et al (2007) Comparative proteomic characterization of articular cartilage tissue from normal donors and patients with osteoarthritis. Arthritis Rheum 56:3675–84CrossRefPubMedGoogle Scholar
  22. 22.
    Tsezou A, Iliopoulos D, Malizos KN, Simopoulou T (2010) Impaired expression of genes regulating cholesterol efflux in human osteoarthritic chondrocytes. J Orthop Res 28:1033–9PubMedGoogle Scholar
  23. 23.
    Findlay DM (2007) Vascular pathology and osteoarthritis. Rheumatology (Oxford) 46:1763–8CrossRefGoogle Scholar
  24. 24.
    Berenbaum F (2013) Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage 21:16–21CrossRefPubMedGoogle Scholar
  25. 25.
    Richette P, Poitou C, Garnero P, et al (2011) Benefits of massive weight loss on symptoms, systemic inflammation and cartilage turnover in obese patients with knee osteoarthritis. Ann Rheum Dis 70:139–44CrossRefPubMedGoogle Scholar
  26. 26.
    Haugen IK, Ramachandran VS, Misra D, et al (2013) Hand osteoarthritis in relation to mortality and incidence of cardiovascular disease: data from the Framingham Heart Study. Ann Rheum Dis 2013 Sep 18. doi:  10.1136/annrheumdis-2013-203789 Google Scholar
  27. 27.
    Rahman MM, Kopec JA, Anis AH, et al (2013) Risk of cardiovascular disease in patients with osteoarthritis: a prospective longitudinal study. Arthritis Care Res (Hoboken) 65:1951–8CrossRefGoogle Scholar
  28. 28.
    Hoeven TA, Kavousi M, Clockaerts S, et al (2013) Association of atherosclerosis with presence and progression of osteoarthritis: the Rotterdam Study. Ann Rheum Dis 72:646–51CrossRefPubMedGoogle Scholar
  29. 29.
    Hoeven TA, Leening MJ, Bindels PJ, et al (2014) Disability and not osteoarthritis predicts cardiovascular disease: a prospective population-based cohort study. Ann Rheum Dis 2014 Jan 2. doi: 10.1136/annrheumdis-2013-204388 Google Scholar
  30. 30.
    Kyrkanides S, Tallents RH, Miller JN, et al (2011) Osteoarthritis accelerates and exacerbates Alzheimer’s disease pathology in mice. J Neuroinflammation 8:112PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag France 2014

Authors and Affiliations

  1. 1.Service de rhumatologie, Hopital Saint-Antoine, Assistance Publique — Hôpitaux de Paris (AP-HP), Département Hospitalo-Universitaire « Inflammation — Immunopathologie — Biothérapie » (DHU i2B)Sorbonne Universités UPMC Univ Paris 06, APHPParisFrance
  2. 2.Centre de Recherche Saint-Antoine, Inserm UMRS_938UPMC Univ Paris 06ParisFrance

Personalised recommendations